Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

说医解药

多个药品批文注销是进口药退场吗?原研药|仿制药 Vol.44

30 Oct 2025

Description

80个药品批文注销,多为进口药,媒体、自媒体惊呼进口药集体退场,原研药加速消失。这是真相吗?一个很简单的核查办法就是去看一下所有80个被注销的批文,我就这样做了,发现事实并非如此。【🎙️时间轴】:00:00 进口药跑路的说法由何而来01:22 51个批文,26款进口药03:10 费卡华瑞:这个进口氯雷他定不仅是仿制,还没多少人用05:42 辉瑞:两个国外已经停产的老药07:24 强生:原料没了,芬太尼不做了,HIV药做不好了10:15 曾经引发轰动的HIV药物遇到定位困境14:39 GSK: 喷雾药的高仿壁垒被突破16:18 默沙东:进口甲肝疫苗不再有竞争力18:21 赛诺菲:鸡肋GLP-1追随海外的退场步伐19:11 诺华:美国已停产的吸入剂19:58 勃林格殷格翰:仿制药冲击糖尿病大品牌22:08 拜耳:被仿制药冲击的重磅药与被FDA撤市的抗癌药23:55 Biogen: 曾经重点引进的罕见病药被仿制药冲击到退货25:01 BioMarin: 唯一冲击患者的退市;原因扑朔迷离28:16 MacroGenics:乳腺癌原研药?其实是被甩卖的原研药30:12 三家不知名外企32:31 三家“勉强”的外资34:56 总结:进口药退场的真相是什么37:05 尾声:一切以证据为重

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.